Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C168606
http://purl.obolibrary.org/obo/NCIT_C168606
|
|---|---|
| Preferred Name | Selective Estrogen Receptor Degrader LX-039 |
| Definitions |
An orally available selective estrogen receptor degrader/downregulator (SERD), with potential antineoplastic activity. Upon oral administration, SERD LX-039 specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that results in ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An orally available selective estrogen receptor degrader/downregulator (SERD), with potential antineoplastic activity. Upon oral administration, SERD LX-039 specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that results in ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells. |
|---|---|
| prefLabel | Selective Estrogen Receptor Degrader LX-039
|
| label | Selective Estrogen Receptor Degrader LX-039
|
| NCI_META_CUI | CL972812
|
| PDQ_Closed_Trial_Search_ID | 800319
|
| code | C168606
|
| Has_Target | |
| prefixIRI | NCIT:C168606
|
| in_subset | |
| Preferred_Name | Selective Estrogen Receptor Degrader LX-039
|
| Maps_To | Selective Estrogen Receptor Degrader LX-039
|
| NCI_Drug_Dictionary_ID | 800319
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 800319
|
| Semantic_Type | Pharmacologic Substance
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |